Related references
Note: Only part of the references are listed.Development of hypotension in patients newly diagnosed with heart failure in UK general practice: retrospective cohort and nested case-control analyses
Mar Martin-Perez et al.
BMJ OPEN (2019)
Impact of the Norepinephrine Prodrug Droxidopa on the QTc Interval in Healthy Individuals
William B. White et al.
CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT (2018)
A perspective on diuretic resistance in chronic congestive heart failure
Niel Shah et al.
THERAPEUTIC ADVANCES IN CARDIOVASCULAR DISEASE (2017)
Cardiovascular Safety of Droxidopa in Patients With Symptomatic Neurogenic Orthostatic Hypotension
William B. White et al.
AMERICAN JOURNAL OF CARDIOLOGY (2017)
The velocity of antihypertensive effects of seven angiotensin II receptor blockers determined by home blood pressure measurements
Michihiro Satoh et al.
JOURNAL OF HYPERTENSION (2016)
Long-term safety of droxidopa in patients with symptomatic neurogenic orthostatic hypotension
Stuart Isaacson et al.
JOURNAL OF THE AMERICAN SOCIETY OF HYPERTENSION (2016)
Effects of Celiprolol and Bisoprolol on Blood Pressure, Vascular Stiffness, and Baroreflex Sensitivity
Kazuo Eguchi et al.
AMERICAN JOURNAL OF HYPERTENSION (2015)
Diuretic response in acute heart failure: clinical characteristics and prognostic significance
Mattia A. E. Valente et al.
EUROPEAN HEART JOURNAL (2014)
Droxidopa for neurogenic orthostatic hypotension A randomized, placebo-controlled, phase 3 trial
Horacio Kaufmann et al.
NEUROLOGY (2014)
Droxidopa in Patients with Neurogenic Orthostatic Hypotension Associated with Parkinson's Disease (NOH306A)
Robert A. Hauser et al.
JOURNAL OF PARKINSONS DISEASE (2014)
Diuretic Strategies in Patients with Acute Decompensated Heart Failure
G. Michael Felker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Contamination of the Norepinephrine Prodrug Droxidopa by Dihydroxyphenylacetaldehyde
Courtney Holmes et al.
CLINICAL CHEMISTRY (2010)
Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function - A report from the Acute Decompensated Heart Failure National Registry (ADHERE) database
CW Yancy et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction
B Pitt et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Share Paper
